Geneos Wealth Management’s Hartford Multifactor US Equity ETF ROUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,000
Closed -$70K 2082
2022
Q3
$70K Hold
2,000
﹤0.01% 919
2022
Q2
$75K Hold
2,000
﹤0.01% 1111
2022
Q1
$84K Hold
2,000
﹤0.01% 1156
2021
Q4
$88K Buy
+2,000
New +$84.5K ﹤0.01% 1220
2021
Q2
Sell
-40,018
Closed -$1.57M 3068
2021
Q1
$1.57M Buy
+40,018
New +$1.46M 0.04% 325
2020
Q2
Sell
-400
Closed -$10K 2610
2020
Q1
$10K Hold
400
﹤0.01% 1828
2019
Q4
$13K Hold
400
﹤0.01% 1878
2019
Q3
$12K Sell
400
-325
-45% -$10.3K ﹤0.01% 1817
2019
Q2
$22K Hold
725
﹤0.01% 1588
2019
Q1
$22K Hold
725
﹤0.01% 1533
2018
Q4
$19K Hold
725
﹤0.01% 1525
2018
Q3
$23K Hold
725
﹤0.01% 1520
2018
Q2
$22K Buy
+725
New +$22.9K ﹤0.01% 1408

Other funds holding ROUS

Geneos Wealth Management's ROUS Position: Q4 2022 in Review

Geneos Wealth Management sold out of Hartford Multifactor US Equity ETF (ROUS) in Q4 2022, closing a stake of 2,000 shares — an estimated $70K sold.

Geneos Wealth Management first reported a position in ROUS in Q2 2018 and held it in 13 quarters. The position peaked at $1.57M in Q1 2021. 46 funds tracked by Wall St. Rank hold ROUS as of Q4 2022.

  • Geneos Wealth Management reported no remaining Hartford Multifactor US Equity ETF position as of Q4 2022 after selling out during the quarter.
  • Geneos Wealth Management sold 2,000 Hartford Multifactor US Equity ETF shares in Q4 2022, an estimated $70K.
  • Geneos Wealth Management first reported a position in Hartford Multifactor US Equity ETF in Q2 2018 and held it in 13 quarters.
  • Geneos Wealth Management's Hartford Multifactor US Equity ETF position peaked at $1.57M in Q1 2021.
  • 46 funds tracked by Wall St. Rank held Hartford Multifactor US Equity ETF as of Q4 2022.

Based on Geneos Wealth Management's 13F filing for Q4 2022, filed 31 Jan 2023.